Sofosbuvir/velpatasvir + GS-9857 for 8 weeks cures hepatitis C for most people with genotype 1 or 3
HCV transmission during anal sex may happen without blood, study in HIV/HCV coinfected men finds
Grazoprevir/elbasvir shows high hepatitis C cure rate for people who inject drugs
People with HIV and HCV co-infection achieve high HCV cure rates with grazoprevir/elbasvir
Hepatitis C incidence remains stable among gay men living with HIV in Europe, but varies across countries
Sofosbuvir/ledipasvir for 8 weeks cures most hard-to-treat hepatitis C patients in real-world study
Successful hepatitis C treatment lowers risk of death for people with HIV and HCV co-infection
Strategies for hepatitis C ‘treatment as prevention’ must address the concerns of people who inject drugs
London clinic survey shows impact of chemsex on condom and PEP use
